Stock GLUE MONTE ROSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Monte Rosa Therapeutics, Inc.

Equities

GLUE

US61225M1027

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
5.94 USD +11.65% Intraday chart for Monte Rosa Therapeutics, Inc. +8.59% +5.13%
Apr. 29 UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating MT
Mar. 14 Monte Rosa Therapeutics Q4 Net Loss Narrows; Shares Decline MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Monte Rosa Therapeutics, Inc. - Special Call
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLUE Stock
  4. News Monte Rosa Therapeutics, Inc.
  5. Transcripts